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Objectives. This study examined the effect of radiofrequency
ablation (RFA) on left atrial (LA) and left atrial appendage (LAA)
function in humans with chronic atrial flutter (AFL).
Background. Atrial stunning and the development of spontane-
ous echocardiographic contrast (SEC) is a consequence of elec-
trical cardioversion of AFL to sinus rhythm. This phenomenon
has been termed “stunning” and is associated with thrombus
formation and embolic stroke. Radiofrequency ablation is now
considered to be definitive treatment for chronic AFL, but whether
this procedure is complicated by LA stunning is unknown.
Methods. Fifteen patients with chronic AFL undergoing cura-
tive RFA underwent transesophageal echocardiography to evalu-
ate LA and LAA function and SEC before and immediately, 30
minutes and 3 weeks after RFA. To control for possible direct
effects of RFA on atrial function, seven patients undergoing RFA
for paroxysmal AFL were also studied. In this group, RF energy
was delivered in sinus rhythm and echocardiographic parameters
were assessed before and immediately and 30 minutes following
RFA.
Results. Chronic AFL: Mean arrhythmia duration was 17.2 6
13.3 months. Twelve patients (80%) developed SEC following RF
energy application and reversion to sinus rhythm. LAA velocities
decreased significantly from 54.0 6 14.2 cm/s in AFL to 18.0 6 7.1
cm/s in sinus rhythm after arrhythmia termination (p < 0.01).
These changes persisted for 30 minutes. Following 3 weeks of
sustained sinus rhythm, significant improvements in LAA veloci-
ties (68.9 6 23.6 vs. 18.0 6 7.1 cm/s, p < 0.01) and mitral A-wave
velocities (49.8 6 10.3 vs. 13.4 6 11.2 cm/s, p < 0.01) were evident
and SEC had resolved in all patients. Paroxysmal AFL: Radiofre-
quency energy delivered in sinus rhythm had no significant effect
on any of the above indexes of LA or LAA function and no patient
developed SEC following RFA.
Conclusions. Radiofrequency ablation of chronic AFL is asso-
ciated with significant LA stunning and the development of SEC.
Left atrial stunning is not secondary to the RF energy application
itself. Sustained sinus rhythm for 3 weeks leads to resolution of
these acute phenomena. Left atrial stunning occurs in the absence
of direct current shock or antiarrhythmic drugs, suggesting that
its mechanism may be a function of the preceding arrhythmia
rather than the mode of reversion.
(J Am Coll Cardiol 1998;32:468–75)
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The cardioversion of atrial fibrillation to sinus rhythm is
associated with transient mechanical dysfunction of the left
atrium (LA) and left atrial appendage (LAA) and the devel-
opment of spontaneous echocardiographic contrast (SEC).
This phenomenon has been termed “stunning” and is consid-
ered an important factor for thromboembolic stroke following
reversion of atrial fibrillation to sinus rhythm (1–5). For this
reason, it is recommended that patients undergo 3 to 4 weeks
of postreversion anticoagulation to reduce the risk of stroke
(6).
Atrial stunning may also occur following the electrical
cardioversion of atrial flutter (AFL) to sinus rhythm (2,7,8).
Although this stunning may be less than that which occurs
following reversion of atrial fibrillation, recent evidence dem-
onstrates that the risk of thromboembolic events in patients
with AFL and who are cardioverted from AFL is significant
(7,9,10).
Curative radiofrequency ablation (RFA) is now considered
by many to be the treatment of choice for patients with chronic
AFL (11–13). Despite the increasing experience with AFL
ablative techniques, whether these procedures are associated
with atrial stunning is unknown and uniform recommendations
for periprocedural anticoagulation have not been adopted.
The aim of this study was to use transesophageal echocar-
diography (TEE) to determine whether atrial stunning occurs
following reversion of chronic AFL to sinus rhythm when
radiofrequency (RF) energy is the mode of reversion. In those
patients in whom atrial mechanical dysfunction was observed
following reversion to sinus rhythm, we also investigated
whether this was reversible in the short and medium term by
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performing repeat transesophageal echocardiographic evalua-
tions 30 minutes and 3 weeks following RFA.
The mechanism of atrial stunning following direct current
(DC) reversion is incompletely understood. Some evidence
suggests that atrial stunning occurs as a result of the preceding
atrial arrhythmia and that atrial stunning represents a form of
tachycardia-mediated atrial cardiomyopathy (14–16). Other
data implicates the DC shock as a significant contributor to the
mechanism of stunning (1,3,4,17–20). The present study pro-
vided an opportunity to determine whether atrial stunning
occurs in the absence of a DC shock or acutely administered
antiarrhythmic agents, thereby gaining some insight into the
mechanisms of this phenomenon. To control for possible direct
effects of RF energy on atrial function, we also studied a group
of patients undergoing RFA for paroxysmal AFL. These
patients had been in sinus rhythm for at least 4 weeks before
the procedure.
Methods
Study patients. The study population comprised 15 male
patients undergoing RFA of chronic AFL. Demographic de-
tails are presented in Table 1. The patients had documented
AFL for 17.2 6 13.3 months and antiarrhythmic drugs had failed
a mean of 2.4 6 0.6 months before RFA. Structural heart
disease was present in six patients and absent in nine patients
other than the presence of atrial dilation. All patients gave
written informed consent to the study, which was approved by
the Board of Medical Research of Royal Melbourne Hospital.
Patient preparation. All antiarrhythmic drugs other than
amiodarone were discontinued more than five half-lives before
RFA and were not recontinued (Table 1). The single patient
taking amiodarone had therapy permanently discontinued four
days before RFA. Radiofrequency ablation was performed
under general anesthesia to facilitate performance of sequen-
tial TEE analyses without patient discomfort. A standardized
general anesthetic with endotracheal intubation and mechan-
ical ventilation was administered with propofol induction
followed by anesthesia maintained with the volatile agent
isoflurane and the muscle relaxant atracurium.
Echocardiographic analysis. Following general anesthesia,
TEE was performed using a 5-MHz phased array multiplane
probe connected to a Hewlett-Packard Sonos 2500 ultrasound
system (Hewlett-Packard, Palo Alto, CA). Images were re-
corded on 0.5 in. super VHS tape and analyzed off-line using
Hewlett-Packard computerized software.
Left atrial and LAA function were assessed at four defined
time points: 1) during chronic AFL immediately before abla-
tion; 2) immediately on reversion of AFL to sinus rhythm;
3) 30 minutes following reversion of AFL to sinus rhythm; and
4) three weeks following the RFA procedure.
Left atrial appendage flow velocities were assessed using
pulsewave Doppler imaging, placing the sample volume 1 cm
into the mouth of the LAA. A multiplane probe was used and
the LAA was scanned in planes from 0° to 130° to establish an
angle at which maximal flow velocities could be obtained. This
angle was retained for all subsequent analyses. The angles
employed in this study ranged from 0° to 95°. All velocity
measurements were performed off-line and averaged over 20
consecutive cardiac cycles. Left atrial appendage areas were
determined by planimetry and measured at the angle at which
LAA flow velocities were obtained. Over 20 consecutive car-
diac cycles, consecutive maximal and minimal LAA areas were
assessed and LAA fractional area change (FAC) was calcu-
lated using the following formula (1): FAC 5 maximum area 2
minimum area/maximum area.
Left atrial function was assessed following AFL termination
with TEE pulsewave interrogation of the mitral inflow at the
level of the mitral valve leaflet tips (points 2 to 4). Doppler
envelopes for the mitral A-wave velocities during AFL were
difficult to obtain and were excluded from the data set. Mitral
A-wave velocities were analyzed off-line and averaged over 20
cardiac cycles.
Table 1. Clinical and Echocardiographic Characteristics of the
Patient Population Undergoing Radiofrequency Ablation of Chronic
Atrial Flutter
Total 15
Age (yr) 57.6 6 14.0
Men 15
Duration of atrial flutter (mo) 17.2 6 13.3 (range 2–24)
Ischemic heart disease 3
ASD repair 1
Mitral valve replacement 1
Dilated cardiomyopathy 1
LA size (cm) 4.8 6 0.4
LVEDD (cm) 5.3 6 0.4
LVESD (cm) 3.2 6 0.5
LVFS (%) 33.1 6 7.6
Drug therapy before study
Amiodarone 1
Sotalol 3
Flecainide 2
Digoxin 3
Beta blocker 2
None 4
ASD 5 atrial septal defect; LA 5 left atrial; LVEDD 5 left ventricular
end-diastolic diameter; LVESD 5 left ventricular end-systolic diameter;
LVFS 5 left ventricular fractional shortening.
Abbreviations and Acronyms
AFL 5 atrial flutter
DC 5 direct current
ECG 5 electrocardiographic, electrocardiography
FAC 5 fractional area change
LA 5 left atrial
LAA 5 left atrial appendage
RF 5 radiofrequency
RFA 5 radiofrequency ablation
SEC 5 spontaneous echocardiographic contrast
TEE 5 transesophageal echocardiography
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Spontaneous echocardiographic contrast was defined by the
appearance of swirling clouds of echogenicity in the left atrium
and LAA distinct from white noise artifact. Gain settings were
reduced sequentially to distinguish SEC from noise and main-
tained for the study duration. SEC was assessed independently
by two observers at the four time points and graded as absent,
mild or marked (21). Spontaneous echocardiographic contrast
analysis was performed off-line and observers were unaware of
patient identification, AFL type (chronic vs. paroxysmal), the
timing of TEE in relation to RFA and the other’s interpreta-
tions. Changes in SEC grading were resolved by consensus.
Left atrial appendage thrombus was defined as a mass adher-
ent to the wall of the LAA with either independent motion or
different echogenicity. Attention was directed at differentiating
pectinate muscles from potential thrombus (8).
All recordings at the time of the RFA (points 1 to 3) were
performed during periods of apnea to minimize potential
velocity variations caused by mechanical ventilation. Trans-
esophageal echocardiography at 3 weeks following the RFA
was performed with intravenous benzodiazepine sedation;
velocity measurements during apnea were not possible.
Atrial flutter definition. Typical AFL was defined by its
characteristic 12-lead surface electrocardiogram. This was con-
firmed at electrophysiologic study on the basis of established
criteria (11–13). These include: 1) counterclockwise activation
sequence in the right atrium in the frontal plane, and 2)
manifest entrainment from the high right atrium and con-
cealed entrainment from within the subeustachian isthmus.
Chronicity was defined as the presence of AFL for at least 14
days. AFL duration was defined as the time from initial 12-lead
ECG diagnosis to the time of the RFA procedure.
Electrophysiological evaluation and ablation. Intracardiac
catheters were positioned following the initial TEE evaluation
to avoid physical termination of AFL before collection of
baseline echocardiographic data. Catheters were placed in the
coronary sinus, His bundle and tricuspid annulus positions as
previously described in detail (11). An 8F ablation catheter was
positioned in the subeustachian isthmus and was used for
entrainment mapping and delivery of RF energy as previously
described (11). In all patients RFA was initially performed
during AFL. After electrophysiologic confirmation of the
flutter mechanism, an anatomic approach was used to create a
line of conduction block between the inferior tricuspid annulus
and the eustachian ridge (11,12). The end point for successful
ablation was the demonstration of bi-directional isthmus block
using well known techniques (11–13). Atrial flutter reinduction
employing rapid atrial pacing following isthmus block was not
attempted. At no time during the procedure were DC shocks
or intravenous antiarrhythmic drugs administered.
All antiarrhythmic drugs discontinued before the ablation
procedure were not recommenced following successful RFA.
All patients received anticoagulation with warfarin until follow
up at 3 weeks. An international normalized ratio of 2.0 to 2.5
was considered satisfactory.
Control Group
Study patients. To assess the direct effect of RF energy
application on atrial mechanical function, seven male patients
(age 62.4 6 14.9 years) with paroxysmal AFL were also
evaluated. These patients were included with the sole purpose
of determining if the procedure itself and the application of RF
energy depressed atrial function. Paroxysmal AFL was defined
by a history of 3 or more episodes of typical AFL confirmed on
a 12-lead electrocardiogram as described previously. No pa-
tient described symptoms attributable to paroxysmal AFL in
the four weeks before RFA. All patients in the control group
were in sinus rhythm before ablation and underwent the same
preoperative preparation as described previously for the group
with chronic AFL.
Paroxysmal AFL had been present for 14.8 6 7.1 months and
a mean of 2.8 6 0.8 antiarrhythmic drugs could not be used
before RFA. Two patients had ischemic heart disease and one
patient had had a Ross procedure for aortic regurgitation.
Structural heart disease other than LA dilation was absent in
four patients. The mean LA dimension was 4.5 6 0.4 cm and
the mean left ventricular end-diastolic dimension was 5.1 6
0.5 cm. Before RFA, three patients were taking amiodarone
and four patients were taking sotalol; these drugs were discon-
tinued 1 week before RFA.
Echocardiographic analysis. Following general anesthesia
and before intracardiac catheter placement, TEE was per-
formed as described above. Left atrial and LAA function at
three defined time points were evaluated (1–3): 1) in sinus
rhythm before ablation; 2) in sinus rhythm, immediately fol-
lowing isthmus block after successful application of RF energy
in the low right atrial isthmus and 3) 30 minutes following
application of RF energy. Transesophageal echocardiography
at three weeks was not performed.
Electrophysiologic evaluation and ablation. Intracardiac
catheter placement in the control group was the same as that
described previously for patients with chronic AFL. Pacing
from the coronary sinus ostium at a cycle length of 600 ms was
used during RFA and success was defined as previously. These
conventional techniques have been described elsewhere (11–
13).
Statistical analysis. All hemodynamic variables are re-
ported as mean 6 SD. A repeated measures analysis of
variance was used to compare continuous variables. Scheffe’s F
test was used for multiple comparisons. Statistical significance
was established at p , 0.05. Seven patients were included in
the paroxysmal AFL control group. This part of the study was
prospectively designed to detect a mean fall in velocity of 14 6
13 cm/s with 80% power (2,20,22).
Results
Chronic Atrial Flutter Group
Radiofrequency ablation. The mean AFL cycle length of
the study population was 255 6 38 ms. In all 15 patients, RFA
was successful in terminating AFL and bi-directional isthmus
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block was achieved in all patients. The mean fluoroscopy time
for the procedure was 28.7 6 11.7 min. The mean number of
RF energy applications was 18 6 11.
Left atrial appendage function (Figs. 1 and 2). The mean
LAA velocity before RFA was 54.0 6 14.2 cm/s. Immediately
following termination of AFL by RF energy, LAA velocity
decreased significantly to 18.0 6 7.2 cm/s during sinus rhythm
(p , 0.01). Re-evaluation 30 minutes following termination of
AFL disclosed no further significant change in LAA velocity
(17.4 6 8.3 vs 18.0 6 7.2 cm/s).
All patients were re-evaluated 3 weeks following RFA. All
patients manifested sinus rhythm as evidenced by discrete
P waves on the 12-lead surface electrocardiogram. The mean
LAA velocity at 3 weeks was 68.9 6 23.6 cm/s, which was
significantly greater than that in sinus rhythm following AFL
termination (18.0 6 7.1 cm/s, p , 0.01), and also significantly
greater than that during AFL before RFA (54.0 6 14.2 cm/s,
p , 0.05). Recovery of LAA mechanical function was seen in
all patients by 3 weeks (Fig. 1).
Left atrial appendage fractional area change (Fig. 3). The
mean preablation LAA FAC was 47.0 6 23.8%. Fractional
area change immediately following termination of AFL was
significantly reduced to 24.5 6 18.9% (p , 0.01). There were
no significant changes in FAC in the subsequent 30 minutes
following AFL termination (24.5 6 18.9% vs. 26.8 6 17.8%).
Left atrial appendage FAC increased significantly from
24.5 6 18.9% immediately after RFA to 68.1 6 14.5% in sinus
rhythm at 3 weeks (p , 0.01). Fractional area change at 3
weeks was also significantly greater than that during AFL
before RFA (68.1 6 14.5% vs. 47.0 6 23.8%, p , 0.05).
Left atrial cavity function (Fig. 4). Mean mitral inflow
A-wave velocity in sinus rhythm following AFL termination
was 13.4 6 11.2 cm/s. There was no significant difference
between the velocity measured immediately following AFL
termination and that of 30 minutes later (12.7 6 11.3 cm/s).
Left atrial cavity function exhibited improvements in contrac-
tility at 3 weeks. The mean mitral inflow A-wave velocity at 3
weeks was significantly greater than that immediately following
AFL termination (49.8 6 10.3 cm/s vs. 13.4 6 11.2 cm/s, p ,
0.01).
Left atrial spontaneous echocardiographic contrast and
thrombus. Spontaneous echocardiographic contrast and LAA
thrombus were absent in all patients before RFA and AFL
termination. Immediately following AFL termination, 12 of 15
patients (80%) developed new LA SEC. Four patients devel-
oped marked SEC and eight developed mild SEC. These
changes persisted at re-evaluation 30 minutes following AFL
termination. No patient developed LA or LAA thrombus in
the interval between AFL termination and reassessment at 30
minutes. The mean LAA velocity immediately following rever-
sion in the 12 patients who developed LA SEC was 16.1 6
7.1 cm/s. This velocity was not significantly different from
that in the 3 patients who did not develop LA SEC (19.6 6
8.7 cm/s).
Spontaneous echocardiographic contrast had resolved by
the 3-week reevaluation in all 12 patients in whom SEC had
Figure 1. Mean LAA emptying velocities (centimeters per
second) in AFL and in sinus rhythm immediately, 30
minutes and 3 weeks following RFA of chronic AFL. SR 5
sinus rhythm; vertical bars 5 mean 6 SD.
Figure 2. Doppler flow envelopes of LAA velocities (centimeters per
second) in chronic AFL (top), in sinus rhythm immediately following
AFL termination (middle) and in sinus rhythm at the 3 week follow-up
assessment (bottom). Vertical axis scale (centimeters per second).
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developed following RFA. No embolic events occurred during
the 3-week follow-up period.
Atrial cycle length. There was no significant difference in
atrial cycle length immediately following compared with 30
minutes following AFL termination (987 6 220 ms vs. 997 6
202 ms). The mean sinus rhythm rate demonstrated no signif-
icant difference from 60 6 16 beats/min at AFL termination to
62 6 10 beats/min at 3 weeks.
Control Group
Radiofrequency ablation. Radiofrequency ablation of par-
oxysmal AFL was successful in all patients. Mean fluoroscopy
time for the procedure was 29.2 6 12.1 min and the mean
number of RF energy applications was 19 6 9. Atrial flutter
was not induced and DC shocks and antiarrhythmic drugs were
not administered during the procedure.
Left atrial appendage function (Fig. 5). Before RFA, the
mean LAA velocity in sinus rhythm was 55.0 6 10.5 cm/s.
Mean LAA velocities in sinus rhythm immediately (58.8 6
12.2 cm/s) and 30 minutes following RFA (57.5 6 10.5 cm/s)
were not significantly different from baseline.
Left atrial appendage fractional area change. Mean LAA
FAC before RFA was 60.0 6 10.5%. Immediately and 30
minutes following RFA, FAC was 58.0 6 10.8% and 55.8 6
11.4%, respectively. These values were not significantly differ-
ent from baseline.
Left atrial cavity function. Mean mitral A-wave velocity
before RFA was 40.4 6 10.0 cm/s. Immediately and 30 minutes
following RFA, mean mitral A-wave velocities were 42.2 6
8.8 cm/s and 44.4 6 8.1 cm/s, respectively. These values were
not significantly different from baseline.
Spontaneous echocardiographic contrast. No patient dem-
onstrated SEC or thrombus before, immediately following, or
30 minutes following RFA.
Sinus rate. There were no significant differences in heart
rate between baseline (65 6 10 beats/min), immediately after
(65 6 8 beats/min) and 30 minutes after RFA (68 6 10
beats/min) values.
Discussion
New findings. This study presents important new informa-
tion regarding the development of atrial mechanical stunning
following termination of chronic AFL.
First, significant atrial stunning occurs following RFA of
chronic AFL. Both LAA and LA velocities became markedly
depressed and a significant number of patients developed SEC.
Second, this phenomenon occurred in the absence of a DC
shock or the administration of antiarrhythmic agents and was
not observed in patients undergoing RFA of paroxysmal AFL.
These observations strongly implicate the preceding atrial
arrhythmia as an important causative factor in the develop-
Figure 3. Mean LAA fractional area change (%) in AFL and
in sinus rhythm immediately, 30 minutes and 3 weeks follow-
ing RFA of chronic AFL. SR 5 sinus rhythm; vertical bars 5
mean 6 SD.
Figure 4. Mean mitral in-flow A-wave velocities (centimeters per
second) in sinus rhythm immediately, 30 minutes and 3 weeks follow-
ing RFA of chronic AFL. SR 5 sinus rhythm; vertical bars 5 mean 6
SD.
Figure 5. Mean LAA emptying velocities (centimeters per second) in
sinus rhythm before, immediately and 30 minutes following RFA of
paroxysmal AFL demonstrating no effect due to the RF lesion itself.
SR 5 sinus rhythm; vertical bars 5 mean 6 SD.
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ment of atrial stunning. Finally, LA and LAA mechanical
function recover toward normal values within 3 weeks follow-
ing RFA of chronic AFL. These findings have important
implications both for the clinical management of patients
undergoing RFA of chronic AFL and for the mechanism of
development of atrial stunning.
Comparison with previous studies. Left atrial stunning
following reversion of atrial flutter to sinus rhythm. Atrial stun-
ning immediately following DC cardioversion of atrial fibrilla-
tion to sinus rhythm has been demonstrated by several studies
(1–5,16,20,22,23). Few studies, however, have examined atrial
function following the reversion of AFL to sinus rhythm (2,7,23).
Grimm et al. (2) compared atrial function before and
immediately following DC cardioversion of atrial fibrillation in
44 patients and AFL in 19 patients using TEE. Significant LA
stunning developed in both groups but was less marked in
those patients with AFL. New or increased SEC developed in
21% of the patients with AFL.
Atrial mechanical dysfunction following DC cardioversion
of AFL has been demonstrated in two studies using trans-
thoracic echocardiography to evaluate transmitral flow. Irani
et al. (7) studied 40 patients with AFL for a mean duration of
4 weeks. Mitral A-wave velocities were absent in 11 of the 40
patients (28%) following cardioversion. Jordaens et al. (23)
used transthoracic echocardiography to assess mitral A-wave
velocities following DC cardioversion in 16 patients and over-
drive pacing in six patients with AFL. All patients received
disopyramide before and after reversion; atrial stunning was
observed in both groups. These studies are limited by the fact
that the mitral A wave cannot be accurately assessed during
AFL and because LAA function and SEC require TEE for
determination.
Although the above studies have evaluated the effect of DC
reversion of AFL on atrial function, we used TEE to demon-
strate that chronic AFL leads to significant atrial stunning
when RF energy is the mode of arrhythmia termination. This is
important because curative RFA is now considered by many to
be the treatment of choice for patients with chronic AFL
(11–13). In the present study, LAA velocities were depressed
to a level that is considered to represent high risk for thrombus
formation; new SEC was observed in 80% of patients (1–4).
The greater degree of atrial stunning and higher incidence of
SEC compared with that observed by Grimm et al. (2) may
reflect the longer duration of AFL in patients included in the
present study.
Unlike larger studies that have demonstrated predisposing
factors to the development of atrial stunning following rever-
sion of atrial fibrillation (3), small patient numbers in the
present study precluded a determination of risk factors for
SEC following RFA of chronic AFL. This should be an
important focus of future research in larger patient cohorts
with AFL.
Recovery of left atrial mechanical function over time. Several
studies have examined the recovery of LA function following
cardioversion of atrial fibrillation to sinus rhythm (3,5,24–26).
Manning et al. (3) employed serial transthoracic echocardiog-
raphy to identify arrhythmia chronicity as a major determinant
of the recovery of atrial function following DC cardioversion of
atrial fibrillation. Serial TEE was used to demonstrate the
return of LA and LAA function 7 days following the endocar-
dial defibrillation of atrial fibrillation by Omran et al. (5).
Recovery of LA mechanical function over time following
reversion of AFL to sinus rhythm has not been studied
extensively. Jordaens et al. (23) used transthoracic echocardi-
ography to evaluate recovery of LA function following DC
cardioversion of AFL. Following cardioversion of AFL to sinus
rhythm, late diastolic filling peak A-wave velocities increased
from 28 cm/s after 1 h to 39 cm/s after 24 h and reached 54 cm/s
after 6 weeks.
Transesophageal echocardiography has been used previ-
ously to evaluate LA mechanical function immediately follow-
ing electrical and spontaneous cardioversion of AFL to sinus
rhythm (2,16). To our knowledge, long-term recovery of LA
and LAA function and the evolution of SEC following rever-
sion of AFL to sinus rhythm has not been studied previously
using TEE. The present study has shown that atrial stunning
resolves and LAA function returns to clinically normal values
following 3 weeks of sustained sinus rhythm. In addition, SEC
that develops following reversion of AFL resolves after 3
weeks of sustained sinus rhythm. These findings suggest that:
1) sustained sinus rhythm following curative ablation of
chronic AFL may lead to normalization of LA and LAA
function and 2) the tachycardia-mediated atrial cardiomyopa-
thy that may be responsible for atrial stunning in AFL is
reversible (14).
Mechanism of atrial stunning. Both low energy internal and
higher energy external defibrillation of atrial fibrillation may
be associated with atrial stunning (1–5,20). Whether DC
energy causes direct damage to atrial myocardium and hence,
is a major determinant of stunning is unclear. Fatkin et al. (4)
demonstrated a relationship between the number and energy
level of DC shocks delivered in atrial fibrillation and the
development of SEC on reversion to sinus rhythm. Manning et
al. (24) suggested that electrical cardioversion of atrial fibril-
lation was associated with more significant atrial stunning than
that occurring during pharmacologic cardioversion. In addi-
tion, other studies have provided direct biochemical and
ultrastructural evidence of myocardial damage following deliv-
ery of DC shocks for ventricular arrhythmias (27,28). In
contrast, other investigators have shown no significant differ-
ences in atrial function following cardioversion achieved
through either DC shock or pharmacologic agents (29), that
external DC shocks delivered during ventricular tachycardia or
sinus rhythm are not associated with atrial stunning (30,31)
and that DC cardioversion of atrial fibrillation is not associated
with an elevation of specific cardiac enzymes such as cardiac
troponin I (32).
This study has shown that significant atrial stunning occurs
following the termination of chronic AFL in the absence of DC
shocks or the administration of antiarrhythmic drugs. Further-
more, the observed effect was not mediated by RF energy
because atrial stunning was not observed in patients with sinus
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rhythm undergoing the same procedure for paroxysmal AFL.
Although the etiology of atrial stunning may be multifactorial
(4,14–20,24,33) results from the present study suggest that
atrial stunning following RFA of chronic AFL may result from
a tachycardia-mediated atrial cardiomyopathy rather than the
mode of cardioversion (14).
Clinical implications. The development of reversible LA
mechanical stunning and SEC following RFA of chronic AFL
suggests that a potential for thromboembolic stroke exists for
which prophylactic anticoagulation should be considered.
These observations suggest that a three-week period of pro-
phylactic anticoagulation may be reasonable following RFA of
chronic AFL.
Emerging evidence demonstrates that chronic AFL is not a
benign condition. Several studies have demonstrated a signif-
icant risk of thromboembolic events in patients with chronic
AFL (9,10). In addition, a high prevalence of SEC and/or atrial
thrombus was found in patients with sustained AFL by Irani et
al. (7). The present study demonstrates that not only is
reversion of chronic AFL to sinus rhythm associated with atrial
stunning but that this reverses over a period of 3 weeks.
Indeed, despite a mean AFL duration of 17 months, LAA
velocities returned to levels approaching that of the normal
population after 3 weeks of sinus rhythm. These data suggest
that the risk of thromboembolic events in patients with chronic
AFL might be effectively reduced by curative RFA. This would
extend the indications for this procedure to include not only
symptomatic patients but all patients with chronic AFL.
The demonstration of significant atrial stunning following
reversion of AFL to sinus rhythm in the absence of DC shock
suggests that atrial stunning is likely to occur irrespective of the
mode of termination. Thus, spontaneous-, pharmacologic- and
pace-terminated reversion of chronic AFL may be potentially
associated with similar degrees of atrial stunning. Prophylactic
anticoagulation should also be considered in these circum-
stances.
Study limitations. To determine whether atrial stunning
following RFA of chronic AFL is reversible, TEE was per-
formed immediately, 30 minutes and 3 weeks following RFA.
A 30-minute period was selected to establish whether atrial
stunning persisted in the short term. A 3-week interval sepa-
rating the ablation procedure from the follow-up TEE was
selected because it approximated the time anticoagulation is
recommended following DC cardioversion of atrial fibrillation
(6). It was not feasible to perform more frequent TEE
examinations in the intervening period; therefore, the exact
time course of recovery of mechanical function could not be
determined.
Patients with paroxysmal AFL were included only to deter-
mine if the application of RF energy during sinus rhythm had
an effect on LA function. A direct comparison with the group
with chronic AFL would have required a much larger group of
patients with paroxysmal AFL.
Conclusion. Transesophageal echocardiography before
and following RFA of chronic AFL has provided insight into
the mechanical changes manifested in the left atrium on
reversion to sinus rhythm without cardioverting DC shock.
After RFA of chronic AFL, significant atrial mechanical
dysfunction occurs with the development of SEC. Sinus rhythm
for 3 weeks following RFA allows recovery of atrial function
with the resolution of SEC. Because atrial stunning and the
development of SEC are strongly associated with embolic
stroke, prophylactic anticoagulation for 3 weeks should be
considered following RFA of chronic AFL. As atrial stunning
was observed in the absence of DC shock or antiarrhythmic
agents, this study suggests that atrial stunning results from
properties of the preceding atrial arrhythmia rather than the
mode of reversion.
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